Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Life Time Group Holdings Inc. Common Stock (LTH) vs Sanofi SA (SNY) Price & Performance

Life Time Group Holdings Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Life Time Group Holdings Inc. Common Stock vs Sanofi SA — how do they compare? Life Time Group Holdings Inc. Common Stock trades at $40.62 (market cap $9.00B), while Sanofi SA trades at $40.07 (market cap $95.18B). The key difference: Sanofi SA is far larger — about 10.6× Life Time Group Holdings Inc. Common Stock's market cap, and Sanofi SA pays a 6.01% dividend while Life Time Group Holdings Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Life Time Group Holdings Inc. Common Stock for 1 Days and Sanofi SA for 94 Days on average.

LTHSNY
Market Cap
$9.00B$95.18B
Volume
2,696,9232,995,646
Sector
Consumer CyclicalHealth
52-Week High
$45.73$52.34
52-Week Low
$24.59$39.51
Typical Hold Time
1 Days94 Days
Enterprise Value
$13.05B$114.48B
Dividend Yield
—6.01%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Life Time Group Holdings Inc. Common Stock

No Aura AI signal available yet.

Sanofi SA

Sanofi (SNY) trades at $40.23, up 0.07% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q2 2026 earnings beat with EPS of $1.21 versus $1.10 expected, continuing a trend of exceeding expectations. Recent expansion of the immunology alliance with Regeneron adds potential for future growth through new antibody programs.

While valuation metrics appear reasonable with P/E of 22.14 and P/S of 1.77, projected 2026 net income decline to $4.0B (8.09% margin) raises concerns. Analyst consensus leans cautious with 44% buy ratings versus 52% hold, suggesting tempered optimism despite recent positive developments.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LTH

No sentiment data available yet.

SNY
35% Buy65% Sell
Avg holding period · 94 Days

Top news

Latest headlines on both assets

About Life Time Group Holdings Inc. Common Stock

Life Time operates fitness and lifestyle centers that offer gyms, classes, sports facilities, and wellness services.

Read more on LTH →

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY →